BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Bio NC

  Fennec Announces Results of Annual Meeting - June 14, 2022

  Fennec Pharmaceuticals Inc. announced that the nominees listed in the management proxy circular dated April 20, 2022 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in New York, New York on June 14, 2022.

  June 14, 2022

   · 

  1 min read
• Business

  Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A - June 14, 2022

  BIOASIS TECHNOLOGIES INC. announced it has filed its audited annual financial statements and management’s discussion and analysis for the period ended February 28, 2022.

  June 14, 2022

   · 

  4 min read
• Business

  Allucent Appoints Katy Moore as President of Growing Clinical Pharmacology, Modeling and Simulation Division

  Global biopharmaceutical services leader, Allucent, announced today the appointment of Katy Moore, PharmD, RPh, as president of Clinical Pharmacology, Modeling and Simulation (CPMS).

  June 14, 2022

   · 

  2 min read
• Drug Development

  Blue Earth Therapeutics Announces Promising Results of Preclinical Biodistribution and Efficacy Evaluation of 177Lu-rhPSMA-10.1 in Treatment of Prostate Cancer

  Blue Earth Therapeutics Announces Promising Results of Preclinical Biodistribution and Efficacy Evaluation of 177 Lu-rhPSMA-10.1 in Treatment of Prostate Cancer.

  June 14, 2022

   · 

  8 min read